| n | Avg age of onset | Avg age at death | Avg disease duration | % female | Avg PMI |
---|
Normal – age-matched
| 15 | N/A | 71.7(8.4) | N/A | 46.7 | 12.7(8.5) |
Normal – non age-matched
| 12 | N/A | 54.5(24.9) | N/A | 66.7 | 9.1(3.4) |
Normal - total
| 27 | N/A | 64.0(19.4) | N/A | 56.7 | 11.1(6.9) |
PSP
| 17 | 66.8(5.8) | 73.7(5.2) | 6. 7(2.2) | 64.7 | 11.7(6.0) |
AD
| 9 | 65.0(6.3) | 75.8(5.1) | 10. 8(3.4) | 44.4 | 9.4(5.8) |
- There were no significant differences between groups for average age at death (ANOVA, p = 0.33), post-mortem interval (ANOVA, p = 0.54), average age of onset (PSP and AD only, Student’s t-test, p = .45) or percent female (Chi Square, p = 0.89). Average disease duration for AD was significantly longer than for PSP (Student’s t-test, p = 0.002). Standard deviations indicated inside parenthesis.